HER2-positive Breast CancerFase 2NCT07102381
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Zanidatamab, Paclitaxel, Docetaxel, Carboplatin
63 estudios reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Mama63 estudios
HER2-positive Breast CancerFase 2NCT07102381
Zanidatamab, Paclitaxel, Docetaxel, Carboplatin
Breast CancerFase 2NCT07054190
Inavolisib, Ribociclib, Letrozole, Giredestrant
Ductal Carcinoma in SituFase 2NCT06075953
Tamoxifen, Exemestane, Letrozole, Anastrazole
Breast CancerFase 2NCT07654257
Partial Breast Irradiation
Breast CancerFase 2NCT07748208
Inavolisib, Fulvestrant, Palbociclib
Breast CancerFase 2NCT06361940
Aromatase inhibitors or tamoxifen
Metastatic Breast Cancer in the LiverFase 2NCT06875128
Melphalan/HDS followed by Physician's choice of SOC (eribulin, vinorelbine, or capecitabine), Physician's choice of SOC (eribulin, vinorelbine, or capecitabine)
Estrogen Receptor-Positive Breast CarcinomaFase 2NCT06450873
Coriolus Versicolor Extract, Questionnaire Administration
Tumores que expresan mesotelinaFase 1NCT06623396Artículos
Terapia con células CAR T dirigidas contra mesotelina en personas con cáncer esofagogástrico
Anatomic Stage IV Breast Cancer AJCC v8Fase 2NCT03606967
Biopsy Procedure, Biospecimen Collection, Carboplatin, Computed Tomography
Breast NeoplasmsFase 2NCT07287098
Imlunestrant, Goserelin, Tamoxifen 20 mg
Breast CancerFase 2NCT07368998
Inavolisib, Fulvestrant
Anatomic Stage I Breast Cancer AJCC v8Fase 2NCT07460752
Biospecimen Collection, Goserelin Acetate, Questionnaire Administration
Breast CancerFase 2NCT01766297
Proton Radiotherapy
Advanced Breast CancerFase 2NCT07427394
Camizestrant, Atirmociclib
Metástasis cerebrales de cáncer de mama HR+/HER2-Fase 1/2NCT04923542
SR y abemaciclib, con o sin imlunestrant, en el manejo de metástasis cerebrales de cáncer de mama HR+/HER2-
Breast Cancer, MetastaticFase 2NCT07007559
Evorpacept (ALX148), Trastuzumab, Paclitaxel, Capecitabine
Cáncer de mama triple negativoFase 2NCT05528133
Genomically Guided Radiation Therapy
ER+ Breast CancerFase 2NCT06923527
Elacestrant
Cáncer de mama triple negativoFase 2NCT06353997
Pembrolizumab, INBRX-106
Advanced Breast CarcinomaFase 2NCT04090567
Cediranib, Ceralasertib, Olaparib
Breast NeoplasmsFase 2NCT06797635
Patritumab deruxtecan, Pembrolizumab, Paclitaxel, Carboplatin
Breast CancerFase 2NCT05570253
Eribulin, SDX-7320, Placebo
Cáncer de mama triple negativoFase 2NCT06245889Artículos
Paclitaxel, Carboplatin, Pembrolizumab, Doxorubicin